Advanced Urine Toxicology Testing

REFERENCES

• Hamett-Stabler , C and Webster , L . 2008 . Clinical guide to urine drug testing monograph , Newark, NJ : University of Medicine and Dentistry of New Jersey, Center for Continuing and Outreach Education .
   Google Scholar
• Webster , L R and Dove , B . 2007 . Avoiding opioid abuse while managing pain: a guide for practitioners , North Branch, MN : Sunrise Press .
   Google Scholar
• Gourlay , D L , Heit , H A and Caplan , Y H . 2006 . Urine toxicology testing in clinical practice: dispelling the myths and designing strategies . J Calif Acad Fam Pract , 1 : 3 – 22 .
   Google Scholar
• Paulozzi , L , Budnitz , D and Yongli , X . 2006 . Increasing deaths from opioid analgesics in the United States . Pharmacoepidemiol Drug Saf , 15 : 618 – 27 .
   PubMed Web of Science ®Google Scholar
• Holler , J M , Bosy , T Z , Klette , K L , Wiegand , R , Jemionek , J and Jacobs , A . 2004 . Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples . J Anal Toxicol , 28 : 489 – 93 .
   PubMed Web of Science ®Google Scholar
• Reisfield , G M , Salazar , E and Bertholf , R L . 2007 . Rational use and interpretation of urine drug testing in chronic opioid therapy . Ann Clin Lab Sci , 37 : 301 – 14 .
   PubMed Web of Science ®Google Scholar
• Schneider , R S , Lindquist , P , Tong-in Wong , E , Rubenstein , E and Ullman , E F . 1973 . Homogeneous enzyme immunoassay for opiates in urine . Clin Chem , 19 : 821 – 5 .
   PubMed Web of Science ®Google Scholar
• Siemens Healthcare Diagnostics, Inc. 2008 . EMIT II Plus® Immunoassay Analyzer for detection of drugs of abuse (DAUs), package insert and Cross-Reactivity List data , Deerfield, IL : Siemens Healthcare Diagnostics, Inc. .
   Google Scholar
• Hewlett-Packard , H P . 2005 . Gas Chromatograph Model 5890-Mass Spectrometer Model 5970 instruction manual and package insert data , Foster City, CA : Agilent Technologies, Quantum Analytics, Inc. .
   Google Scholar
• NYS Mental Hygiene Law: Sections 19.05(f), 19.07(b), 23.01. Requirements for the operation of chemotherapy substance abuse programs. Title 14 of the official compilation of codes, rules and regulations of the State of New York. Part 828, Section 828.12. 2000
   Google Scholar
• Bush , D M . 2008 . The U.S. mandatory guidelines for federal workplace drug testing programs: current status and future considerations . Forensic Sci Int , 174 : 111 – 19 .
   PubMed Web of Science ®Google Scholar
• Katz , N and Fanciiuollo , G . 2008 . Role of urine toxicology testing in the management of chronic opioid therapy . Clin J Pain , 18 : S76 – 82 .
   Google Scholar
• Michna , E , Jamison , R N , Pham , L D , Ross , E L , Janfaza , D , Nedeljkovic , S S , Narang , S , Palombi , D and Wasan , A D . 2007 . Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings . Clin J Pain , 23 : 173 – 9 .
   PubMed Web of Science ®Google Scholar
• Ives , T J , Chelminski , P R , Hammett-Stabler , C A , Malone , R M , Perhac , J S , Potisek , N M , Shilliday , B B , DeWalt , D A and Pignone , M P . 2006 . Predictors of opioid misuse in patients with chronic pain: a prospective cohort study . BMC Health Serv Res , 6 : 46
   PubMed Web of Science ®Google Scholar
• Katz , N , Sherburne , S and Beach , M. 2003 . Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy . Anesth Analg , 97 : 1097 – 102 .
   PubMed Web of Science ®Google Scholar
• Fleming , M F , Balousek , S T , Kessig , C I , Mundt , M and Brown , D D . 2007 . Substance use disorders in a primary care sample receiving daily opioiod therapy . J Pain , 8 : 573 – 82 .
   PubMed Web of Science ®Google Scholar
• Chermack , S T , Roll , J , Reilly , M , Davis , L , Kilaru , U and Grabowski , J . 2000 . Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions . Drug Alcohol Depend , 59 : 43 – 9 .
   PubMed Web of Science ®Google Scholar
• Smith , M L , Hughes , R O , Levine , B , Dickerson , S , Darwin , W D and Cone , E J . 1995 . Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry . J Anal Toxicol , 19 : 18 – 26 .
   PubMed Web of Science ®Google Scholar
• Compton , P . 2007 . The role of urine toxicology in chronic opioid analgesic therapy . J Pain Manag , 8 : 166 – 72 .
   Google Scholar
• Reisfield , G M , Webb , F J , Bertholf , R L , Sloan , P A and Wilson , G R . 2007 . Family physicians' proficiency in urine drug test interpretation . J Opioid Manag , 3 : 333 – 37 .
   PubMedGoogle Scholar
• Reisfield , G M , Bertholf , R , Barkin , R L , Webb , F and Wilson , G . 2007 . Urine drug test interpretation: what do physicians know . Clin J Pain , 3 : 80 – 6 .
   Google Scholar
• Dunn , K E , Sigmon , S C , McGee , M R , Heil , S H and Higgins , S T . 2008 . Evaluation of ongoing oxycodone abuse among methadone-maintained patients . JSAT , 35 : 451 – 56 .
   Google Scholar
• Levy , S , Harris , S K , Sherritt , L , Angulo , M and Knight , J R . 2006 . Drug testing of adolescents in ambulatory medicine: physician practices and knowledge . Arch Pediatr Adolesc Med , 160 : 146 – 50 .
   PubMedGoogle Scholar
• Brunton , L , Lazo , J and Parker , K . 2005 . Goodman and Gilman's the pharmacological basis of therapeutics. , 11th ed. , New York, NY : McGraw-Hill .
   Google Scholar
• Reisfield , G M and Bertholf , R L . 2008 . “Practical guide” to urine drug screening clarified . Mayo Clin Proc , 83 : 848 – 9 .
   PubMed Web of Science ®Google Scholar
• Von Seggern , R , Fitzgerald , C P , Adelman , L C and Adelman , U . 2004 . Laboratory monitoring of OxyContin (Oxycodone): clinical pitfalls . Headache: JHAFP , 44 : 44 – 7 .
   PubMed Web of Science ®Google Scholar
• Backer , R C , Monforte , J R and Poklis , A . 2005 . Evaluation of the DRI oxycodone immunoassay for the detection of oxycodone in urine . J Anal Toxicol , 29 : 675 – 77 .
   PubMed Web of Science ®Google Scholar
• CSAT: the Center for Substance Abuse Treatment . 2005 . Medication-assisted treatment for opioid addiction in opioid treatment programs , Rockville, MD : Substance Abuse and Mental Health Services Administration . Treatment Improvement Protocol (TIP) Series, No. 43. DHHS Publication No. (SMA) 05–4048
   Google Scholar
• Narayanaswami , K , Golani , H CC and Dua , R D . 1979 . Assay of major and minor constituents of opium samples and studies of their origin . Forensic Sci Int , 14 : 181 – 90 .
   PubMed Web of Science ®Google Scholar
• Francis , P S , Adcock , J L , Costin , J W , Purcell , S D , Pfeffer , F M and Barnett , N W . 2008 . Chemiluminescene detection of opium poppy alkaloids . J Pharmacol and Biochem Anal , 4 : 508 – 18 .
   Google Scholar
• Rook , E J , van Ree , J M , van den Brink , W , Hillebrand , M J , Huitema , A D , Hendriks , V M and Beijnen , J H . 2006 . Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients . Basic Clin Pharmacol Toxicol , 98 : 86 – 96 .
   PubMed Web of Science ®Google Scholar
• Smith , M L , Shimomura , E T , Summers , J , Paul , B D , Jenkins , A J , Darwin , W D and Cone , E J . 2001 . Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin . J Anal Toxicol , 25 : 504 – 14 .
   PubMed Web of Science ®Google Scholar
• Mule , S J and Casell , G A . 1988 . Rendering “the poppy seed defense” defenseless: identifying 6-monoacetylmorphine in the urine by gas chromatography/mass spectroscopy . Clin Chem , 34 : 1427 – 30 .
   PubMed Web of Science ®Google Scholar
• O'Neal , C L and Poklis , A . 1998 . Detection of acetylcodieine and 6-monoacetyl morphine in opiate positive urines . Forensic Sci Int , 95 : 1 – 14 .
   PubMed Web of Science ®Google Scholar
• Rook , E J , Huitema , A D , van den Brink , W , van Ree , J M and Beijnen , J H . 2006 . Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature . Curr Clin Pharmacolog , 1 : 109 – 18 .
   PubMedGoogle Scholar
• Jenkins , A J , Lavins , E S and Snyder , A . 2005 . Evaluation of the cedia heroin metabolite 6-MAM immunoassay with urine specimens from a criminal justice drug-testing program . J Anal Toxicol , 29 : 201 – 4 .
   PubMed Web of Science ®Google Scholar
• Posey , B L and Kimble , S N . 1984 . High-performance liquid chromatographic study of codeine, norcodeine, and morphine as indicators of codeine ingestion . J Anal Toxicol , 8 : 68 – 74 .
   PubMed Web of Science ®Google Scholar
• MacDonald , D and Ferguson , J . 2002 . “ Chapter 3: Drug Urine Toxicology Testing ” . In The Medical Review Officer , 127 – 243 . Chevy Chase, MD : American Society of Addiction Medicine Publications .
   Google Scholar
• Kircheimer , J , Schmidt , H , Tzvetkov , M , Keulen , J T , Lotsch , J , Roots , I and Brockmoller , J . 2007 . Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication . Pharmacogenomics Journal , 7 : 257 – 65 .
   PubMed Web of Science ®Google Scholar
• Susce , M T , Murray-Carmichael , E and de Leon , J . 2006 . Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer . Prog Neuropsychopharmacol Biol Psychiatry , 30 : 1356 – 8 .
   PubMed Web of Science ®Google Scholar
• Brockmoller , J , Schmidt , H , Roots , I and Kircheiner , J . 2008 . CYP2D6 ultrarapid metabolism and morphine/codeine ratios: was it codeine or heroin? . J Anal Toxicol , 32 : 178 – 82 .
   PubMed Web of Science ®Google Scholar
• Selavka , C M . 1991 . Poppy seed ingestion as a contributing factor to opiate-positive urinalysis results: the Pacific perspective . J Forensic Sci , 36 : 685 – 96 .
   PubMed Web of Science ®Google Scholar
• Struempler , R E . 1987 . Excretion of codeine and morphine following ingestion of popoy seeds . J Anal Toxicol , 11 : 97 – 9 .
   PubMed Web of Science ®Google Scholar
• Hayes , L W , Krasselt , W G and Mueggler , P A . 1987 . Concentrations of morphine and codeine in serum and urine after ingestion of poppy seeds . Clin Chem , 33 : 806
   PubMed Web of Science ®Google Scholar
• Meadway , C , George , S and Braithwaite , R . 1998 . Opiate concentrations following the ingestion of poppy seed products-evidence for “the poppy seed defense” . Forensic Sci Int , 96 : 29 – 38 .
   PubMed Web of Science ®Google Scholar
• Rook , E J , Huitema , A D , van den Brink , W , van Ree , J M and Beijnen , J H . 2004 . Population pharmacokinetics of heroin and its major metabolites . Clinical Pharmacokinet , 45 : 401 – 17 .
   Web of Science ®Google Scholar
• Straley , C M , Cecil , E J and Herriman , M P . 2006 . Gatifloxacin interference with opiate urine drug screen . Pharmacotherapy , 26 : 435 – 9 .
   PubMed Web of Science ®Google Scholar
• Meatherall , R and Dai , J . 1997 . False-positive EMIT II opiates from ofloxacin . Ther Drug Monit , 19 : 98 – 9 .
   PubMed Web of Science ®Google Scholar
• Baden , L , Horowitz , G and Eliopoulos , G . 2001 . Quinolones and false-positive urine screening for opiates by immunoassay technology . JAMA , 286 : 3115 – 9 .
   PubMed Web of Science ®Google Scholar
• Zacher , J L and Givone , D M . 2004 . False-positive urine opiate screening associated with fluoroquinolone use . Ann Pharmacother , 38 : 1525 – 8 .
   PubMed Web of Science ®Google Scholar
• Hull , M J , Bierer , M F , Griggs , D A , Long , W H , Nixon , A L and Flood , J G . 2008 . Urinary buprenorphine concentrations in patients treated with suboxone as determined by liquid chromatography-mass spectrometry and CEDIA immunoassay . J Anal Toxocol , 32 : 516 – 21 .
   PubMed Web of Science ®Google Scholar
• Böttcher , M and Beck , O . 2005 . Evaluation of buprenorphine CEDIA assay versus GC-MS and ELISA using urine samples from patients in substitution treatment . J Anal Toxicol , 29 : 769 – 76 .
   PubMed Web of Science ®Google Scholar
• Winstock , A R , Lea , T and Jackson , A P . 2009 . Methods and motivations for buprenorphine diversion from public opioid substitution treatment clinics . J Addict Dis , 28 : 57 – 63 .
   PubMed Web of Science ®Google Scholar
• Kosten , T R and Fiellin , D A . 2004 . U.S. National Buprenorphine Implementation Program. Buprenorphine for office-based practice: consensus conference overview . Am J Addict , 13 : S1 – 7 .
   PubMed Web of Science ®Google Scholar
• Kaferstein , H and Sticht , G . 2000 . Comparison of nonradioactive microtiter plate enzyme immunoassays for the sensitive detection of fentanyl . Forensic Sci Int , 11 : 353 – 7 .
   Google Scholar
• Poklis , A . 1995 . Fentanyl: a review for clinical and analytical toxicoligists . J Toxicol , 33 : 439 – 44 .
   PubMed Web of Science ®Google Scholar
• Poklis , A and Backer , R . 2004 . Urine concentrations of fentanyl and norfentanyl during application of Duragesic transdermal patches . Anal Toxicol , 28 : 422 – 5 .
   PubMed Web of Science ®Google Scholar
• Mao , C L , Zientek , K D , Colahan , P T , Kuo , M Y , Liu , C H , Lee , K M and Chou , C C . 2006 . Development of an enzyme-linked immunosorbent assay for fentanyl and applications of fentanyl antibody-coated nanoparticles for sample preparation . J Pharm Biomed Anal , 41 : 1332 – 41 .
   PubMed Web of Science ®Google Scholar
• Cheever , M L , Armendariz , G A and Moody , D E . 1999 . Detection of methadone, LAAM, and their metabolites by methadone immunoassays . J Anal Toxicol , 23 : 500 – 5 .
   PubMed Web of Science ®Google Scholar
• Fitzgerald , R L and Herold , D A . 1997 . Improved CEDIA benzodiazepine assay eliminates sertraline crossreactivity . J Anal Toxicol , 21 : 32 – 5 .
   PubMed Web of Science ®Google Scholar
• Lum , G , Mushlin , B and Farney , L . 2008 . False-positive rates for the qualitative analysis of urine benzodiazepines and metabolites with the reformulated Abbott Multigent reagents . Clin Chem , 54 : 220 – 1 .
   PubMed Web of Science ®Google Scholar
• Dade-Behring Corporation . 2008 . Integrated services division Newark, DE Personal Communication
   Google Scholar
• Manchon , M , Verdier , M F , Pallud , P , Vialle , A , Beseme , F and Bienvenu , J . 1985 . Evaluation of EMIT-TOX Enzyme Immunoassay for the analysis of benzodiazepines in serum: usefulness and limitations in an emergency laboratory . J Anal Toxicol , 9 : 209 – 12 .
   PubMed Web of Science ®Google Scholar
• Augsburger , M , Rivier , L and Mangin , P . 1998 . Comparison of different immunoassays and GC-MS screening of benzodiazepines in urine . J Pharm Biomed Anal , 18 : 681 – 7 .
   PubMed Web of Science ®Google Scholar
• Huang , W and Moody , D E . 1995 . Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood . J Anal Toxicol , 19 : 333 – 42 .
   PubMed Web of Science ®Google Scholar